Over 20 drug companies marketing anti-obesity drug sibutramine under a variety of brand names are likely to soon face a ban on selling the medicine. The apex drug regulator, Drugs Controller......
In an indication of India's growing importance as a clinical trial destination, multinational pharmaceutical firms are queuing up for approvals to test their new drugs here. At least a dozen global......
What on earth is the Delhi High Court up to? Two of its learned judges are coolly ignoring statutory regulations and seeking to mandate a link between drug regulation and patents where none exists......
Roche Scientific Company (India) Ltd, the local arm of Swiss drug maker F Hoffman-La Roche, will launch a new-generation rheumatoid arthritis drug, Actemra, in India, even as it awaits approvals......
Hospitals and medical research organisations that conduct clinical trials on humans may soon face surprise inspections from the regulatory authorities. The hospitals, the sponsor pharma companies......